Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in The Guangdong Healthcare Setting in China
Abstract
Authors
J Zhou BY Huang M Yang
J Zhou BY Huang M Yang
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now